Article Text

Download PDFPDF

EP096/#1356  Combination of CAFS and CD8+ T cells tumor-to-stroma ratio in predicting value of the lymph node metastases of cervical cancer
  1. Pei Yu Chen,
  2. Shuang Shuang Guo,
  3. Liang-Sheng Fan and
  4. Wei Wang
  1. The First Affiliated Hospital of Guangzhou Medical University, Department of Obstetrics and Gynaecology, Guangzhou, China


Introduction Objective: To explore the cancer-associated fibroblasts (CAFs) and CD8+ T cells tumor-to-stroma ratio (T:S ratio) in cervical cancer tissue and its association with the clinicopathological indexes, and to study the predictive significance of CAFs combined with CD8+ T cells T:S ratio in lymph node metastasis of cervical cancer.

Methods One hundred and ten cervical cancer tissues and thirty-nine biopsy tissues from patients were investigated immunocytochemically for the CAFs and the account of CD8+ T cells using the streptavidin-biotin-peroxidase method with respective monoclonal antibodies. The statistical correlation analysis was carried out using Spearman’s correlation test and χ2 test analysis by the SPSS system.

Results Statistical analysis also revealed a correlation (r=-0.690; P<0.001) between CAFs and CD8+ T cells T:S ratio in cervical cancer. It was found that a higher CAFs and CD8+ T cells T:S ratio had a significant correlation with lymph node metastases (P < 0.001). To further analysis, the combination of CAFs and CD8+ T cells T:S ratio correlated with lymph node metastases (P < 0.001). ROC curves analysis showed that the ROC curves areas for CAFs, CD8+ T cells T:S ratio, and combination of both are 0.879 (95%CI 0.809–0.946), 0.747 (95%CI 0.654–0.841) and 0.951 (95%CI 0.912–0.991). The prediction model was verified by biopsy specimens and consistent results were obtained.

Conclusion/Implications Conclusions: The combination of CAFs and CD8+ T cells T:S ratio has a high predictive value for lymph node metastasis in patients with cervical cancer. Their sensitivity and specificity are high, indicating they may hold considerable clinical value.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.